My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Suzlon Energy gains on winning repeat order
Apr 11,2017

The announcement was made after market hours yesterday, 10 April 2017.

Meanwhile, the S&P BSE Sensex was up 56.22 points, or 0.19% to 29,631.96.

On the BSE, 16.84 lakh shares were traded in the counter so far, compared with average daily volumes of 80.92 lakh shares in the past one quarter. The stock had hit a high of Rs 19.80 and a low of Rs 19.55 so far during the day.

The stock hit a 52-week high of Rs 19.85 on 31 March 2017. The stock hit a 52-week low of Rs 12.47 on 9 November 2016.

The stock had outperformed the market over the past one month till 10 April 2017, rising 12.83% compared with 2.17% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 29.43% as against Sensexs 9.95% rise.

The mid-cap company has equity capital of Rs 1,004.88 crore. Face value per share is Rs 2.

Suzlon Energy said it has won a repeat order of 50.40 megawatts (MW) wind power project in Karnataka from a leading independent power producer (IPP) company. The project will be completed by June 2017. Suzlon will execute the entire project on a turnkey basis and will also provide operation and maintenance services.

On a consolidated basis, Suzlon Energy reported net profit of Rs 274.34 crore in Q3 December 2016 compared with net loss of Rs 121.84 crore in Q3 December 2015. Net sales rose 75.68% to Rs 3307.48 crore in Q3 December 2016 over in Q3 December 2015.

The Suzlon Group is one of the leading renewable energy solutions providers in the world with an international presence across 19 countries in Asia, Australia, Europe, Africa and North and South America.

Powered by Capital Market - Live News

InterGlobe Aviation takes off on high volume
Apr 10,2017

Meanwhile, the S&P BSE Sensex was down 130.87 points or 0.44% at 29,575.74.

Bulk deal boosted volume on the scrip. On the BSE, 3.60 lakh shares were traded on the counter so far as against the average daily volumes of 43,709 shares in the past one quarter. The stock had hit a high of Rs 1,097.50 and a low of Rs 1,031 so far during the day.

The stock had hit a 52-week high of Rs 1,095.40 on 5 May 2016 and a 52-week low of Rs 702 on 11 February 2016. The stock had outperformed the market over the past one month till 7 April 2017, rising 18.7% compared with 2.69% rise in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 23.71% as against Sensexs 11.01% rise.

The large-cap company has equity capital of Rs 361.47 crore. Face value per share is Rs 10.

InterGlobe Aviations net profit fell 25.1% to Rs 487.26 crore on 16.76% growth in total income to Rs 5158.43 crore in Q3 December 2016 over Q3 December 2015.

InterGlobe Aviation is the operator of low cost passenger airline IndiGo.

Powered by Capital Market - Live News

Foreign brokerage upgrade boosts Welspun India
Apr 10,2017

Meanwhile, the S&P BSE Sensex was down 117.28 points, or 0.39%, to 29,589.33. The S&P BSE Mid-Cap was up 80.74 points, or 0.57%, to 14,313.90.

On BSE, so far 4.48 lakh shares were traded in the counter, compared with average daily volume of 3.12 lakh shares in the past one quarter. The stock hit a high of Rs 91.10 and a low of Rs 86.75 so far during the day. The stock hit a record high of Rs 119.90 on 14 June 2016. The stock hit a 52-week low of Rs 46.35 on 30 August 2016.

The stock had underperformed the market over the past one month till 7 April 2017, falling 1.69% compared with 2.69% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, gaining 20.46% as against Sensexs 11.01% rise.

The mid-cap company has equity capital of Rs 100.47 crore. Face value per share is Re 1.

The foreign brokerage reportedly expects 15% revenue growth in the year ending 31 March 2019 (FY 2019) and over 20% growth in earnings per share (EPS). The new flooring capacity will also be operational in FY 2020 and can add 8-9% to FY 2020 revenue growth, the foreign brokerage reportedly said in a research report.

Welspun Indias consolidated net profit fell 16.2% to Rs 149.38 crore on 1.2% rise in net sales to Rs 1306.77 crore in Q3 December 2016 over Q3 December 2015

Welspun India is the leading home fashions supplier in the USA and amongst the top 3 global manufacturers of bed and bath linen.

Powered by Capital Market - Live News

Liquor stocks slide after MP govt mulls ban
Apr 10,2017

Radico Khaitan (down 6.98%), United Spirits (down 5.29%), Associated Alcohols & Breweries (down 5%), Pioneer Distilleries (down 4.9%), Tilaknagar Industries (down 4.06%), G M Breweries (down 3.94%), United Breweries (down 3.5%) and Empee Distilleries (down 1.17%), edged lower. Khoday India was up 1.64%.

Meanwhile, the S&P BSE Sensex was down 126.05 points, or 0.42% at 29,580.56.

Madhya Pradesh is reportedly headed towards total prohibition with Chief Minister Shivraj Singh Chouhan announcing that all liquor shops would be closed across the state in a phased manner.

Alcohol prohibition will be implemented in the entire state by closing all liquor shops in a phased manner, Chouhan announced on Sunday, 9 April 2017, while addressing a programme at village Neemkhera (Heerapur) of Narsinghpur district. In the first phase, the state government closed all the shops falling within a radius of five kilometers from the banks of river Narmada on either side. In the next phase, the liquor shops would not be allowed to open in residential localities, near educational institutes or religious places, he reportedly said.

According to reports, a de-addiction drive would also be launched in the state.

Powered by Capital Market - Live News

Sterling Tools spurts after bulk deal
Apr 10,2017

Meanwhile, the S&P BSE Sensex was down 56.36 points, or 0.19% to 29,650.25

Bulk deal boosted volume on the scrip. On BSE, so far 3.44 lakh shares were traded in the counter as against an average daily volume of 5,565 shares in the past one quarter. The stock hit a high of Rs 235 in intraday trade so far, which is record high for the counter. The stock hit a low of Rs 220.60 so far during the day. The stock had hit a 52-week low of Rs 86.20 on 2 June 2016.

The stock had outperformed the market over the past one month till 7 April 2017, surging 6.14% compared with 2.69% rise in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 16.69% as against Sensexs 11.01% rise.

The small-cap companys equity capital is Rs 6.84 crore. Face value per share is Rs 2.

Sterling Tools net profit rose 85.69% to Rs 12.59 crore on 1.32% rise in total income to Rs 87.28 crore in Q3 December 2016 over Q3 December 2015.

Sterling Tools is engaged in the manufacturing and marketing of high tensile cold forged fasteners. Over the years, it has become one of the leading OEM suppliers in India with a client base that spans leading automotive companies in India, Europe and USA.

Powered by Capital Market - Live News

NIIT tumbles after CEO resigns
Apr 10,2017

The announcement was made after market hours on Friday, 7 April 2017.

Meanwhile, the S&P BSE Sensex was down 74.94 points, or 0.25% to 29,631.67.

On the BSE, 22.85 lakh shares were traded in the counter so far, compared with average daily volumes of 2.01 lakh shares in the past one quarter. The stock had hit a high of Rs 80.40 and a low of Rs 73.80 so far during the day.

The stock hit a 52-week high of Rs 107.80 on 20 September 2016. The stock hit a 52-week low of Rs 67 on 9 November 2016.

The stock had outperformed the market over the past one month till 7 April 2017, rising 9.66% compared with 2.69% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, falling 6.49% as against Sensexs 11.01% rise.

The small-cap company has equity capital of Rs 33.15 crore. Face value per share is Rs 2.

NIIT said that its chief executive officer (CEO), Rahul Keshav Patwardhan, tendered his resignation due to compelling family reasons and has requested to be relieved from the close of business hours of 31 July 2017. The Board has accepted his resignation at its meeting held on 7 April 2017.

Further, the board of directors has approved the appointment of Sapnesh Lalla as chief executive officer designate of the company from 7 April 2017 and as chief executive officer of the company with effect from 1 August 2017.

On a consolidated basis, net profit of NIIT declined 56.20% to Rs 6 crore on 1.91% rise in net sales to Rs 267.30 crore in Q3 December 2016 over Q3 December 2015.

NIIT, a global leader in skills and talent development, offers multi-disciplinary learning management and training delivery solutions to corporations, institutions, and individuals in over 40 countries. NIIT has three main lines of business across the globe- corporate learning group, skills and careers group, and school learning group.

Powered by Capital Market - Live News

Volumes jump at Shiva Cement counter
Apr 10,2017

Shiva Cement clocked volume of 45.83 lakh shares by 13:20 IST on BSE, a 70.81-times surge over two-week average daily volume of 65,000 shares. The stock rose 1.08% to Rs 23.50.

Sterling Tools notched up volume of 3.43 lakh shares, a 40.65-fold surge over two-week average daily volume of 8,000 shares. The stock rose 4.88% to Rs 232.

Moschip Semiconductor Technology saw volume of 32.09 lakh shares, a 12.98-fold surge over two-week average daily volume of 2.47 lakh shares. The stock rose 9.98% to Rs 52.90.

Linde India clocked volume of 1.08 lakh shares, a 12.52-fold surge over two-week average daily volume of 9,000 shares. The stock jumped 8.9% to Rs 473.90.

NIIT saw volume of 21.90 lakh shares, a 7.88-fold rise over two-week average daily volume of 2.78 lakh shares. The stock dropped 6.22% to Rs 77.70.

Powered by Capital Market - Live News

Cox & Kings gains on bottom fishing
Apr 10,2017

Meanwhile, the S&P BSE Sensex was down 104.37 points, or 0.35%, to 29,602.24. Meanwhile, the S&P BSE Mid-Cap index was up 33.76 points, or 0.24%, to 14,266.92

On the BSE, so far 11,000 shares were traded in the counter, compared with average daily volumes of 41,685 shares in the past one quarter. The stock had hit a high of Rs 216.35 and a low of Rs 212.20 so far during the day. The stock hit a 52-week high of Rs 242 on 19 September 2016. The stock hit a 52-week low of Rs 146.20 on 31 May 2016.

The mid-cap company has equity capital of Rs 88.28 crore. Face value per share is Rs 5.

The stock had outperformed the market over the past one month till 7 April 2017, surging 13.84% compared with 2.69% rise in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 13.81% as against Sensexs 11.01% rise.

Cox & Kings consolidated net profit slumped 84.81% to Rs 15.23 crore on 19.9% decline in net sales to Rs 1373.89 crore in Q3 December 2016 over Q3 December 2015.

Cox & Kings is a leading leisure and education travel group with operations in 22 countries across 4 continents. C&K operates in three key verticals: leisure, education and hybrid hotels.

Powered by Capital Market - Live News

RBL Bank zooms 21.12% in seven sessions
Apr 10,2017

Meanwhile, the S&P BSE Sensex was down 55.72 points, or 0.19% at 29,650.89.

On the BSE, 5.95 lakh shares were traded on the counter so far as against the average daily volumes of 3.19 lakh shares in the past one quarter. The stock had hit a high of Rs 598.70 so far during the day, which is also its record high. The stock had hit a low of Rs 561.05 so far during the day.

The stock had hit a 52-week low of Rs 273.70 on 31 August 2016. The stock had outperformed the market over the past one month till 7 April 2017, advancing 17.52% compared with the Sensexs 2.44% rise. The scrip had also outperformed the market over the past one quarter advancing 56.54% as against the Sensexs 11.01% rise.

The large-cap bank has equity capital of Rs 375.20 crore. Face value per share is Rs 10.

Shares of RBL Bank zoomed 21.12% in seven trading sessions to its current ruling price of Rs 588.40, from a close of Rs 485.80 on 29 March 2017.

RBL Banks net profit rose 58.8% to Rs 128.69 crore on 39% growth in net total income to Rs 1143.48 crore in Q3 December 2016 over Q3 December 2015.

RBL Bank is a private sector bank. It currently services over two million customers through a network of 215 branches and 374 ATMs spread across 16 Indian states and Union Territories. The bank offers specialized services under six business verticals namely: Corporate & Institutional Banking, Commercial Banking, Branch & Business Banking, Agribusiness Banking, Development Banking and Financial Inclusion, Treasury and Financial Markets Operations.

Powered by Capital Market - Live News

Sobha tops losers on BSEs A group
Apr 10,2017

Sobha slipped 8.47% at Rs 380.35. The stock topped the losers in A group. On the BSE, 80,000 shares were traded on the counter so far as against the average daily volumes of 6.24 lakh shares in the past two weeks.

Reliance Communications slipped 3.83% at Rs 37.70. The stock was the second biggest loser in A group. On the BSE, 14.66 lakh shares were traded on the counter so far as against the average daily volumes of 19.31 lakh shares in the past two weeks.

Indiabulls Housing Finance slipped 2.83% at Rs 928.40 . The stock was the third biggest loser in A group. On the BSE, 44,000 shares were traded on the counter so far as against the average daily volumes of 9.37 lakh shares in the past two weeks.

Oracle Financial Services Software slipped 2.52% at Rs 3,737.90. The stock was the fourth biggest loser in A group. On the BSE, 3,430 shares were traded on the counter so far as against the average daily volumes of 9.56 lakh shares in the past two weeks.

Prestige Estates Projects slipped 2.28% at Rs 216.30. The stock was the fifth biggest loser in A group. On the BSE, 6,886 shares were traded on the counter so far as against the average daily volumes of 52,000 shares in the past two weeks.

Powered by Capital Market - Live News

Indiabulls Ventures drops after recent rally
Apr 10,2017

The announcement was made after market hours on Friday, 7 April 2017.

Meanwhile, the S&P BSE Sensex was up 25.89 points, or 0.09% at 29,732.50. The S&P BSE Small-Cap index was up 121.28 points, or 0.83% at 14,802.70.

On the BSE, 13.64 lakh shares were traded on the counter so far as against the average daily volumes of 10.48 lakh shares in the past one quarter. The stock hit a high of Rs 74.15 in intraday trade so far, which is 52-week high for the counter. The stock hit a low of Rs 67.15 so far during the day. The stock had hit a 52-week low of Rs 14.55 on 9 May 2016.

The stock had outperformed the market over the past one month till 7 April 2017, surging 94.36% compared with 2.69% rise in the Sensex. The scrip had also outperformed the market in past one quarter, galloping 225.58% as against Sensexs 11.01% rise.

The small-cap company has equity capital of Rs 64.04 crore. Face value per share is Rs 2.

Indiabulls Ventures board of directors at its meeting held on 7 April 2017, approved preferential offer and issue of 3.88 crore equity shares at Rs 58.40 per share to Cinnamon Capital, a foreign portfolio investor. The total equity investment by Cinnamon Capital would aggregate to Rs 226.97 crore. The issue of shares is to augment long-term resources of the company for meeting funding requirements for business purposes, Indiabulls Ventures said.

Indiabulls Ventures consolidated net profit fell 54.1% to Rs 10.59 crore on 9.6% decline in total income from operation to Rs 96.93 crore in Q3 December 2016 over Q3 December 2015.

Indiabulls Ventures (Formerly known as Indiabulls Securities) is one of the leading company in the segment of Capital Market and Real Estate marketing and distribution.

Powered by Capital Market - Live News

Ajanta Pharma rises after USFDA clears Dahej facility
Apr 10,2017

The announcement was made during trading hours today, 10 April 2017.

Meanwhile, the S&P BSE Sensex was up 19.42 points, or 0.07% to 29,726.03.

On the BSE, 26,000 shares were traded in the counter so far, compared with average daily volumes of 25,063 shares in the past one quarter. The stock had hit a high of Rs 1,818 and a low of Rs 1,718.50 so far during the day. The stock hit a record high of Rs 2,150 on 28 October 2016. The stock hit a 52-week low of Rs 1,400.05 on 24 June 2016.

The stock had underperformed the market over the past one month till 7 April 2017, rising 0.45% compared with 2.69% rise in the Sensex. The scrip had also underperformed the market in past one quarter, falling 4.14% as against Sensexs 11.01% rise.

The large-cap company has equity capital of Rs 17.60 crore. Face value per share is Rs 2.

Ajanta Pharma announced that its formulation facility at Dahej was inspected by US Food and Drug Administration (USFDA) from 3rd to 7th April 2017. At the end of the inspection, no Form 483 was issued to the company.

An FDA Form 483 is issued to firm management at the conclusion of an inspection when an investigator has observed any conditions that in their judgement may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related Acts.

On a consolidated basis, net profit of Ajanta Pharma rose 25.15% to Rs 142.60 crore on 9.68% rise in net sales to Rs 515.02 crore in Q3 December 2016 over Q3 December 2015.

Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages.

Powered by Capital Market - Live News

Sobha tumbles on stake sale by promoter
Apr 10,2017

The announcement was made after market hours on Friday, 7 April 2017.

Meanwhile, the S&P BSE Sensex was up 48.24 points, or 0.16% at 29,754.85. The S&P BSE Mid-cap index was up 88.62 points, 0.62% at 14,321.78.

On the BSE, 68,000 shares were traded on the counter so far as against the average daily volumes of 1.17 lakh shares in the past one quarter. The stock had hit a high of Rs 403.95 and a low of Rs 378.50 so far during the day.

The stock had hit a 52-week high of Rs 423.30 on 7 April 2017 and a 52-week low of Rs 224.05 on 22 November 2016. The stock had outperformed the market over the past one month till 7 April 2017, advancing 27.47% compared with the Sensexs 2.44% rise. The scrip had also outperformed the market over the past one quarter advancing 56.25% as against the Sensexs 11.01% rise.

The mid-cap company has equity capital of Rs 96.30 crore. Face value per share is Rs 10.

Sobha said that the promoter Sobha Menon sold 40 lakh shares, or 4.15% stake at price of Rs 414.90 per share. Promoter Sobha Menon held 41.90% stake as per share holding as on 31 December 2016.

Adawi Investments Holdings bought 41.60 lakh shares at price of Rs 414.89 per share of the company.

Sobhas consolidated net profit rose 7.9% to Rs 39.40 crore on 24.4% increase in net sales to Rs 540 crore in Q3 December 2016 over Q3 December 2015.

Sobha Group is one of the largest real estate organisations in India and the Middle East. It has presence in 24 cities and 13 states across India and throughout the Middle East.

Powered by Capital Market - Live News

Divis Laboratories jumps as USFDA alters import alert list
Apr 10,2017

The announcement was made on Saturday, 8 April 2017.

Meanwhile, the S&P BSE Sensex was up 34.67 points, or 0.12% to 29,741.28.

On the BSE, 3.07 lakh shares were traded in the counter so far, compared with average daily volumes of 2.78 lakh shares in the past one quarter. The stock had hit a high of Rs 656.15 and a low of Rs 642.75 so far during the day. The stock hit a record high of Rs 1,380 on 16 September 2016. The stock hit a 52-week low of Rs 611.60 on 22 March 2017.

The stock had underperformed the market over the past one month till 7 April 2017, falling 18.09% compared with 2.69% rise in the Sensex. The scrip had also underperformed the market in past one quarter, falling 15.59% as against Sensexs 11.01% rise.

The large-cap company has equity capital of Rs 53.09 crore. Face value per share is Rs 2.

Divis Laboratories said the United States Food and Drug Administration (USFDA) has exempted some more products manufactured at the companys Unit-II at Visakhapatnam from the import alert issued under clauses 66-40 & 99-32 of the FDA regulations.

An import alert prohibits the company to manufacture or market that particular drug in the United States, according to the regulators website.

Last month, Divis Laboratories announced that the USFDA issued an Import Alert 66-40 on 20 March 2017 on the products manufactured at the companys Unit-II at Visakhapatnam, Andhra Pradesh. The agency has exempted the 10 products namely Levetiracetam, Gabapentin, Lamotrigine, Capecitabine, Naproxen Sodium, Raltegravir potassium, Atovaquone, Chloropurine , BOC core succinate and 2, 4-wing active ester, from the import alert, it added.

Divis Laboratories net profit rose 8.7% to Rs 268.32 crore on 13.4% increase in net sales to Rs 973.44 crore in Q3 December 2016 over Q3 December 2015.

Divis Laboratories is primarily engaged in the manufacture of active pharmaceutical ingredients (APIs) & intermediates for generics; custom synthesis of APIs and advanced intermediates for discovery compounds for pharma giants; building blocks for peptides; building blocks for nucleotides; carotenoids; and chiral ligands.

Powered by Capital Market - Live News

Apollo Tyres inflates after inaugurating Hungarian plant
Apr 10,2017

The announcement was made after market hours on Friday, 7 April 2017.

Meanwhile, the BSE Sensex was up 5.15 points, or 0.02%, to 29,711.76.

On BSE, so far 1.53 lakh shares were traded in the counter, compared with average daily volume of 3.36 lakh shares in the past two weeks. The stock hit a high of Rs 217.50 and a low of Rs 214.50 so far during the day. The stock hit a 52-week high of Rs 235 on 6 October 2016. The stock hit a 52-week low of Rs 139.35 on 24 June 2016.

The stock had outperformed the market over the past one month till 7 April 2017, rising 18.23% compared with 2.69% rise in the Sensex. The scrip had also outperformed the market in past one quarter, surging 12.75% as against Sensexs 11.01% rise.

The large-cap company has equity capital of Rs 50.90 crore. Face value per share is Re 1.

Apollo Tyres announced inauguration of the companys sixth global tyre manufacturing unit and the second one in Europe. Located less than 100 km from the capital Budapest, it is the companys first greenfield facility outside India. Built over 72 hectares, construction began on site in April 2015.

Apollo Tyres is investing Euro 475 million in this facility. The final capacity at the end of phase I would be 5.5 million passenger car & light truck (PCLT) tyres and 675,000 commercial vehicle tyres. This facility will complement Apollo Tyres existing facility in the Netherlands, and will produce both Apollo and Vredestein brand of tyres for the European market.

Speaking on the occasion Onkar S Kanwar, Chairman, Apollo Tyres said that the Hungarian facility will help the company further increase its presence and market share in Europe. From being a replacement market focussed company in Europe, the company would soon be starting supplies of tyres to all the leading OEs in Europe.

Apollo Tyres consolidated net profit rose 5.98% to Rs 295.70 crore on 17.76% increase in total income to Rs 3495.21 crore in Q3 December 2016 over Q3 December 2015.

Apollo Tyres is an international tyre major with manufacturing units in India, the Netherlands and Hungary. The company markets its products under its two global brands - Apollo and Vredestein. The companys products are available in over 100 countries through a network of branded, exclusive and multi-product outlets.

Powered by Capital Market - Live News